en · de · es · fr · pt
thymosin-alpha-1-notes.peptides6608.com › Guide › Molecular Background And Immune Action — Reference Sheet

Molecular Background And Immune Action — Reference Sheet

By Editorial Desk · published 2026-05-19 · last reviewed 2026-06-11 · Guide

A practical reference on Immunomodulatory peptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-06-11. Anything still debated is marked as such rather than presented as settled.

Molecular Background and Immune Action

Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.

Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.

Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.

Handling, Storage, and Analytical Methods

Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.

The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.

Thymosin-alpha-1 at a glance

PropertyValueNotes
Molecular mass≈3,108 DaSynthetic 28-residue peptide
Amino acid count28N-terminal serine carries an acetyl group
AppearanceWhite to off-white powderLyophilized solid
Water solubilityFreely solubleDissolves in aqueous buffer
Common synonymsThymalfasin; Tα1Thymalfasin is the international nonproprietary name

Molecular Structure and Biological Background

The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.

Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.

Related pages on this site

Storage Stability and Analytical Testing

Several factors accelerate degradation: alkaline pH, elevated temperature, exposure to oxidants, and the presence of residual moisture. Deamidation of asparagine residues and oxidation of methionine are the most commonly reported degradation routes. Because the peptide lacks disulfide bonds, it does not undergo the thiol-related aggregation seen in some other biologics, but physical aggregation can still occur at high concentration. Stability data are product-specific, and extrapolating shelf life between formulations is not reliable.

Lyophilized thymosin alpha-1 is generally stored at or below minus twenty degrees Celsius, protected from moisture and light. Short-term handling at ambient temperature is possible for dry powder, but reconstituted solutions degrade faster and are usually kept at two to eight degrees Celsius with a defined expiry of days rather than weeks. Repeated freeze-thaw cycles should be avoided because they promote aggregation and loss of potency. Exact limits depend on the formulation and should follow the supplier's documentation.

Notes from published material

Endochondral ossification, or intracartilaginous ossification, is the formation of long bones and other bones. This requires a hyaline cartilage precursor. There are two centers of ossification for endochondral ossification. The primary center In long bones, bone tissue first appears in the diaphysis (middle of shaft). Chondrocytes multiply and form trabeculae. Cartilage is progressively eroded and replaced by hardened bone, extending towards the epiphysis. A perichondrium layer surrounding the cartilage forms the periosteum, which generates osteogenic cells that then go on to make a collar that encircles the outside of the bone and remodels the medullary cavity on the inside. The nutrient artery enters via the nutrient foramen from a small opening in the diaphysis. It invades the primary center of ossification, bringing osteogenic cells (osteoblasts on the outside, osteoclasts on the inside.) The canal of the nutrient foramen is directed away from more active end of bone when one end grows more than the other. When bone grows at same rate at both ends, the nutrient artery is perpendicular to the bone. Most other bones (e.g. vertebrae) also have primary ossification centers, and bone is laid down in a similar manner. Secondary centers The secondary centers generally appear at the epiphysis. Secondary ossification mostly occurs after birth (except for distal femur and proximal tibia which occurs during 9th month of fetal development).

Fast recognition and treatment of MH utilizes skills and procedures that are utilized with a low-frequency and high-risk. Conducting MH crisis training for perioperative teams can identify system failures as well as improve response to these events. Simulation techniques to include the use of cognitive aids have also been shown to improve communication in clinical treatment of MH.

=== Governors (1947–1958) === Gaston Mourgues (6 September 1947 – 29 April 1948), acting Albert Mouragues (29 April 1948 – 23 February 1953) Salvador Jean Étcheber (23 February 1953 – 3 November 1956) Yvon Bourges (3 November 1956 – 15 July 1958) Max Berthet (15 July 1958 – 11 December 1958), acting

== Dietary recommendations == The US National Academy of Medicine does not distinguish between K1 and K2 – both are counted as vitamin K. When recommendations were last updated, in 1998, sufficient information was not available to establish an estimated average requirement or recommended dietary allowance, as for most vitamins. In instances such as these, the academy defines adequate intakes (AIs) as amounts that appear to be sufficient to maintain good health, with the understanding that at some later date, AIs will be replaced by more exact information. The current AIs for adult women and men ages 19 and older are 90 and 120 μg/day, respectively, for pregnancy, 90 μg/day, and for lactation, 90 μg/day. For infants up to 12 months, the AI is 2.0–2.5 μg/day; for children ages 1–18 years the AI increases with age from 30 to 75 μg/day. As for safety, the academy sets tolerable upper intake levels (known as "upper limits") for vitamins and minerals when evidence is sufficient. Vitamin K has no upper limit, as human data for adverse effects from high doses are not sufficient. In the European Union, adequate intake is defined the same way as in the US. For women and men over age 18 the adequate intake is set at 70 μg/day, for pregnancy 70 μg/day, and for lactation 70 μg/day. For children ages 1–17 years, adequate intake values increase with age from 12 to 65 μg/day. Japan set adequate intakes for adult women at 65 μg/day and for men at 75 μg/day.

Sources: en.wikipedia.org

Background from the literature

Histology (also known as microanatomy or histoanatomy) is the branch of medicine that studies the microscopic anatomy of biological tissues. Histology is the microscopic counterpart to gross anatomy, which looks at larger structures visible without a microscope. Histopathology is the branch of histology that includes the microscopic identification and study of diseased tissue.

==== Power generation ==== The unique properties of sCO2 present advantages for closed-loop power generation and can be applied to power generation applications. Power generation systems that use traditional air Brayton and steam Rankine cycles can use sCO2 to increase efficiency and power output. The relatively new Allam power cycle uses sCO2 as the working fluid in combination with fuel and pure oxygen. The CO2 produced by combustion mixes with the sCO2 working fluid. A corresponding amount of pure CO2 must be removed from the process (for industrial use or sequestration). This process reduces atmospheric emissions to zero. sCO2 promises substantial efficiency improvements. Due to its high fluid density, sCO2 enables compact and efficient turbomachinery. It can use simpler, single casing body designs while steam turbines require multiple turbine stages and associated casings, as well as additional inlet and outlet piping. The high density allows more compact, microchannel-based heat exchanger technology. For concentrated solar power, carbon dioxide critical temperature is not high enough to obtain the maximum energy conversion efficiency. Solar thermal plants are usually located in arid areas, so it is impossible to cool down the heat sink to sub-critical temperatures. Therefore, supercritical carbon dioxide blends, with higher critical temperatures, are in development to improve concentrated solar power electricity production.

==== Chorion ==== The chorionic membrane is a fibrous tissue layer containing the fetal blood vessels. Chorionic villi form on the outer surface of the chorion, which maximise surface area for contact with maternal blood. The chorionic villi are involved in fetal-maternal exchange.

=== Other === Other bodily fluids and organs may provide samples, particularly samples collected during an autopsy. A common autopsy sample is the gastric contents of the deceased, which can be useful for detecting undigested pills or liquids that were ingested prior to death. In highly decomposed bodies, traditional samples may no longer be available. The vitreous humour from the eye may be used, as the fibrous layer of the eyeball and the eye socket of the skull protects the sample from trauma and adulteration. Other common organs used for toxicology are the brain, liver, and spleen.

A black neon tetra inadvertently caused their owner's credit card to be charged during a 2023 livestream by "Mutekimaru Channel" on YouTube. The owner was using motion-tracking software to turn the fish's movements into Nintendo Switch inputs, letting them "play" video games. In 2020, the fish beat Pokemon Sapphire after 3,195 hours, a feat that takes about 30 hours for a typical human. On January 14, 2023, Pokémon Violet crashed at 1,144 hours, giving the fish free access to the main menu. They entered inputs that opened Nintendo eShop, added 500 yen ($3.85 USD) to their owner's account, and exposed his credit card details on the livestream. Mutekimaru later requested a refund of the 500 yen from Nintendo. Several media outlets facetiously described the fish as having committed "credit card fraud". The fish also downloaded an N64 emulator, set up PayPal, used reward points to buy an avatar, and changed Mutekimaru's Nintendo account name to "ROWAWAWA¥". After about seven hours, their movements shut down the Switch.

Sources: en.wikipedia.org

Further detail

In June 2011, the twelfth edition of the National Toxicology Program (NTP) Report on Carcinogens (RoC) changed the listing status of formaldehyde from "reasonably anticipated to be a human carcinogen" to "known to be a human carcinogen." Concurrently, a National Academy of Sciences (NAS) committee was convened and issued an independent review of the draft US EPA IRIS assessment of formaldehyde, providing a comprehensive health effects assessment and quantitative estimates of human risks of adverse effects.

Harassment and bullying are persistent problems, particularly when they relate to discriminatory conduct. Harassment is unlawful based on similar protected characteristics as general equal treatment rights in different statutes, although there is not yet a single coherent codification of standards. Disability Discrimination Act 1992 For example, under the Sex Discrimination Act 1984 section 28A, sexual harassment means conduct of a sexual nature, that is unwelcome, where a 'reasonable person' would have been offended, humiliated or intimidated'. This is also unlawful under the Australian Human Rights Commission Act 1986 section 3, and enables courts to pay compensate for loss or damage. Under section 28B it is unlawful for a person to sexually harass their employee, and employers are vicariously liable for conduct of any employee to another where a breach is "in connection with" employment. For example, in Richardson v Oracle Corporation Australia Pty Ltd the Federal Court awarded $130,000 in compensation for persistent sexual slurs against the claimant, who was forced to resign from her job, up from $18,000 given at first instance. In South Pacific Restor Hotels v Trainor an employer was held liable for harassment after work hours, but in accommodation provided by the employer. However employers may avoid liability if they have taken "all reasonable steps" to prevent harassment, which will usually mean swift action after a complaint.

An earlier study of this family disclosed that the two anemic children and the father, who was not anemic, had sickling erythrocytes while the mother, two sisters and two brothers of the anemic children had non-sickling erythrocytes and were not anemic.In the paper published in the Proceedings of the National Academy of Sciences of the United States of America, Itano presented the need to have naming convention for the different types of hemoglobin, and introduced the alphabet-coding system such as hemoglobin a (for normal adult type), b (sickle cell type), c (sickle cell-associated type) and d (for the novel type); as he explained:In order to facilitate the discussion in the present paper and to avoid confusion in future works, it seems desirable at this time to establish a system of symbols for identifying the various forms of adult human hemoglobin... normal hemoglobin, sickle cell hemoglobin, the abnormal hemoglobin reported by Itano and Neel, and the abnormal hemoglobin reported in the present paper will be designated adult human hemoglobins a, b, c and d, respectively, more briefly as hemoglobins a, b, c and d.It was the discovery of hemoglobin D and creation of hemoglobin naming system. In 1953, Amoz Immanuel Chernoff at the Washington University School of Medicine, St. Louis, introduced the capitalised-letter designation such as A (for normal adult type), C (second abnormal type), D (third abnormal type), S (sickle cell type) and F (fetal form).

cytoplasm All of the material contained within a cell excluding (in eukaryotes) the nucleus; i.e. that part of the protoplasm which is enclosed by the plasma membrane but separated from the nucleoplasm by the nuclear envelope, consisting of the fluid cytosol and the totality of its contents, including all of the cell's internal compartments, organelles, and substructures such as mitochondria, lysosomes, the endoplasmic reticulum, vesicles and inclusions, and a network of filamentous microtubules known as the cytoskeleton. Some definitions of cytoplasm exclude certain organelles such as vacuoles and plastids. Composed of about 80 percent water, the numerous small molecules and macromolecular complexes dissolved or suspended within the cytoplasm give it characteristic viscoelastic and thixotropic properties, allowing it to behave variously as a gel or a liquid solution. Though continuous throughout the intracellular space, the cytoplasm can often be resolved into distinct phases of different density and composition, such as an endoplasm and ectoplasm. Most of the metabolic and biosynthetic activities of the cell take place in the cytoplasm, including protein synthesis by ribosomes. Despite their physical separation, the cytoplasm and the nucleus are mutually dependent upon each other, such that an isolated nucleus without cytoplasm is as incapable of surviving for long periods as is the cytoplasm without a nucleus.

=== Human biosynthesis === Morphine is an endogenous opioid in humans. Various human cells are capable of synthesizing and releasing it, including white blood cells. The primary biosynthetic pathway for morphine in humans consists of

Sources: en.wikipedia.org

Frequently asked questions

What is thymosin alpha 1 made of?

It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.

Is thymosin alpha 1 a hormone?

It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.

Where is thymosin alpha 1 approved?

Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.

How should thymosin alpha 1 be stored?

The lyophilized powder is kept refrigerated at 2 to 8 degrees Celsius and protected from light. Reconstituted solutions should be used promptly. Freezing and thawing repeatedly is avoided.

Network